$3.79
0.112.99%
最終更新: Oct 21, 4:54 PM
Benzinga
Benzinga
Benzinga
土曜日, 10 24
Benzinga
© 2026 Benzinga | All Rights Reserved
Revelation Biosciences (REVB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.83 | $-1.15 | $-2.76 | $-1.34 |
| Actual | $-0.87 | $-2.71 | $-1.65 | $-1.77 |
| Surprise | -4.82% | -135.7% | +40.2% | -32.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | — | — | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-6.16 | $-5.98 |
| Revenue | ||
| Consensus | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.87 | $-0.83 | -4.82 % |
| Q1 | May 7, 2026 | $-2.71 | $-1.15 | -135.7 % |
| Q4 | Feb 26, 2026 | $-1.65 | $-2.76 | 40.2 % |
| Q3 | Nov 6, 2025 | $-1.77 | $-1.34 | -32.1 % |